| Year |
Citation |
Score |
| 2009 |
Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 106: 14670-5. PMID 19667196 DOI: 10.1073/Pnas.0903563106 |
0.733 |
|
| 2009 |
Liu L, Wang J, Zhao L, Nilsen J, McClure K, Wong K, Brinton RD. Progesterone increases rat neural progenitor cell cycle gene expression and proliferation via extracellularly regulated kinase and progesterone receptor membrane components 1 and 2. Endocrinology. 150: 3186-96. PMID 19359388 DOI: 10.1210/En.2008-1447 |
0.654 |
|
| 2008 |
Brinton RD, Thompson RF, Foy MR, Baudry M, Wang J, Finch CE, Morgan TE, Pike CJ, Mack WJ, Stanczyk FZ, Nilsen J. Progesterone receptors: form and function in brain. Frontiers in Neuroendocrinology. 29: 313-39. PMID 18374402 DOI: 10.1016/J.Yfrne.2008.02.001 |
0.603 |
|
| 2008 |
Irwin RW, Yao J, Hamilton RT, Cadenas E, Brinton RD, Nilsen J. Progesterone and estrogen regulate oxidative metabolism in brain mitochondria. Endocrinology. 149: 3167-75. PMID 18292191 DOI: 10.1210/En.2007-1227 |
0.75 |
|
| 2008 |
Nilsen J. Estradiol and neurodegenerative oxidative stress. Frontiers in Neuroendocrinology. 29: 463-75. PMID 18275991 DOI: 10.1016/j.yfrne.2007.12.005 |
0.385 |
|
| 2007 |
Nilsen J, Irwin RW, Gallaher TK, Brinton RD. Estradiol in vivo regulation of brain mitochondrial proteome. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 14069-77. PMID 18094246 DOI: 10.1523/Jneurosci.4391-07.2007 |
0.721 |
|
| 2007 |
Nilsen J, Irwin RW, Yao J, Brinton RD. P-073: Prevention of Alzheimer's pathology: Estrogen targeting of mitochondrial function Alzheimer's & Dementia. 3: S122-S122. DOI: 10.1016/J.Jalz.2007.04.326 |
0.747 |
|
| 2006 |
Nilsen J, Chen S, Irwin RW, Iwamoto S, Brinton RD. Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function. Bmc Neuroscience. 7: 74. PMID 17083736 DOI: 10.1186/1471-2202-7-74 |
0.722 |
|
| 2006 |
Chen S, Nilsen J, Brinton RD. Dose and temporal pattern of estrogen exposure determines neuroprotective outcome in hippocampal neurons: therapeutic implications. Endocrinology. 147: 5303-13. PMID 16916950 DOI: 10.1210/en.2006-0495 |
0.571 |
|
| 2006 |
Nilsen J, Morales A, Brinton RD. Medroxyprogesterone acetate exacerbates glutamate excitotoxicity. Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology. 22: 355-61. PMID 16864144 DOI: 10.1080/09513590600863337 |
0.567 |
|
| 2006 |
Nilsen J, Irwin RW, Brinton RD. P4-390: Brain mitochondria as therapeutic target for the prevention of Alzheimers pathology Alzheimer's & Dementia. 2: S632-S633. DOI: 10.1016/J.Jalz.2006.05.2131 |
0.71 |
|
| 2005 |
Nilsen J, Deng J, Brinton RD. Impact of clinically relevant progestins on the neural effects of estradiol and the signaling pathways involved. Drug News & Perspectives. 18: 545-53. PMID 16421627 DOI: 10.1358/dnp.2005.18.9.948450 |
0.576 |
|
| 2005 |
Alvarez-de-la-Rosa M, Silva I, Nilsen J, Pérez MM, GarcÃa-Segura LM, Avila J, Naftolin F. Estradiol prevents neural tau hyperphosphorylation characteristic of Alzheimer's disease. Annals of the New York Academy of Sciences. 1052: 210-24. PMID 16024764 DOI: 10.1196/annals.1347.016 |
0.492 |
|
| 2005 |
Lowell J, Vazquez MC, Swerdlow R, Khan S, Fagan T, David D, Nilsen J, Smigrodzki R, Reddy PH, Leski M, Brinton RD, Pugh M. Alzheimer Research Forum Live Discussion: A "Mitochondrial Cascade Hypothesis" for sporadic Alzheimer's disease Journal of Alzheimer's Disease. 8: 311-315. DOI: 10.3233/Jad-2005-8310 |
0.587 |
|
| 2005 |
Nilsen J, Irwin RW, Masri R, Diaz Brinton R. [P-200]: Estrogen regulation of mitochondrial function: Target for therapeutics to prevent Alzheimer's disease Alzheimer's & Dementia. 1: S71-S72. DOI: 10.1016/J.Jalz.2005.06.258 |
0.703 |
|
| 2004 |
Nilsen J, Brinton RD. Mitochondria as therapeutic targets of estrogen action in the central nervous system. Current Drug Targets. Cns and Neurological Disorders. 3: 297-313. PMID 15379606 DOI: 10.2174/1568007043337193 |
0.671 |
|
| 2004 |
Brinton RD, Nilsen J. P1-426 Divergent impact of progestins in vitro predicts Alzheimer's disease risk in women using hormone therapy Neurobiology of Aging. 25: S220. DOI: 10.1016/S0197-4580(04)80738-3 |
0.543 |
|
| 2004 |
Nilsen J, Brinton RD. P1-355 Estrogen regulates mitochondrial function: mechanisms for protection against degenerative insults Neurobiology of Aging. 25: S199. DOI: 10.1016/S0197-4580(04)80667-5 |
0.63 |
|
| 2003 |
Brinton RD, Nilsen J. Effects of estrogen plus progestin on risk of dementia. Jama. 290: 1706; author reply 1. PMID 14519699 DOI: 10.1001/Jama.290.13.1706-A |
0.515 |
|
| 2003 |
Nilsen J, Brinton RD. Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling. Proceedings of the National Academy of Sciences of the United States of America. 100: 10506-11. PMID 12925744 DOI: 10.1073/pnas.1334098100 |
0.591 |
|
| 2003 |
Nilsen J, Diaz Brinton R. Mechanism of estrogen-mediated neuroprotection: regulation of mitochondrial calcium and Bcl-2 expression. Proceedings of the National Academy of Sciences of the United States of America. 100: 2842-7. PMID 12604781 DOI: 10.1073/pnas.0438041100 |
0.377 |
|
| 2002 |
Nilsen J, Brinton RD. Impact of progestins on estradiol potentiation of the glutamate calcium response. Neuroreport. 13: 825-30. PMID 11997695 DOI: 10.1097/00001756-200205070-00018 |
0.568 |
|
| 2002 |
Nilsen J, Chen S, Brinton RD. Dual action of estrogen on glutamate-induced calcium signaling: mechanisms requiring interaction between estrogen receptors and src/mitogen activated protein kinase pathway. Brain Research. 930: 216-34. PMID 11879813 DOI: 10.1016/S0006-8993(02)02254-0 |
0.545 |
|
| 2002 |
Nilsen J, Brinton RD. Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. Endocrinology. 143: 205-12. PMID 11751611 DOI: 10.1210/endo.143.1.8582 |
0.633 |
|
| 2000 |
Song J, Sapi E, Brown W, Nilsen J, Tartaro K, Kacinski BM, Craft J, Naftolin F, Mor G. Roles of Fas and Fas ligand during mammary gland remodeling. The Journal of Clinical Investigation. 106: 1209-20. PMID 11086022 DOI: 10.1172/Jci10411 |
0.385 |
|
| 2000 |
Mor G, Kohen F, Garcia-Velasco J, Nilsen J, Brown W, Song J, Naftolin F. Regulation of fas ligand expression in breast cancer cells by estrogen: functional differences between estradiol and tamoxifen. The Journal of Steroid Biochemistry and Molecular Biology. 73: 185-94. PMID 11070347 DOI: 10.1016/S0960-0760(00)00081-9 |
0.414 |
|
| 2000 |
Nilsen J, Mor G, Naftolin F. Estrogen-regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the Fas/Fas ligand system. Journal of Neurobiology. 43: 64-78. PMID 10756067 DOI: 10.1002/(SICI)1097-4695(200004)43:1<64::AID-NEU6>3.0.CO;2-7 |
0.509 |
|
| 1999 |
Mor G, Nilsen J, Horvath T, Bechmann I, Brown S, Garcia-Segura LM, Naftolin F. Estrogen and microglia: A regulatory system that affects the brain. Journal of Neurobiology. 40: 484-96. PMID 10453051 DOI: 10.1002/(SICI)1097-4695(19990915)40:4<484::AID-NEU6>3.0.CO;2-C |
0.507 |
|
| 1999 |
Bechmann I, Mor G, Nilsen J, Eliza M, Nitsch R, Naftolin F. FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: evidence for the existence of an immunological brain barrier. Glia. 27: 62-74. PMID 10401633 DOI: 10.1002/(SICI)1098-1136(199907)27:1<62::AID-GLIA7>3.0.CO;2-S |
0.434 |
|
| 1998 |
Nilsen J, Mor G, Naftolin F. Raloxifene induces neurite outgrowth in estrogen receptor positive PC12 cells. Menopause (New York, N.Y.). 5: 211-6. PMID 9872486 DOI: 10.1097/00042192-199805040-00005 |
0.435 |
|
| Show low-probability matches. |